Introduction:
Dr. Imran Sajid is working in the field of antibiotics research and drugs discovery. Isolation and validation of multidrug resistant (MDR) and extensively drug resistant (XDR) bacterial pathogens, emergence of antibiotics resistance and the strategies to combat the antibiotics resistance. The research group specializes in the isolation, identification and screening of antibiotics producing bacteria, the Streptomyces and rare actinobacteria, from unexplored areas, laboratory scale fermentations, purification and structure elucidation of antibacterial compounds, antitumor/anticancer agents, antifungal, and insecticidal compounds. In-vitro bioassays including antimicrobial, antitumor and anticancer assays, microbial whole genome sequencing (WGS) and genome mining of antibiotics producing bacteria, and application of the genomics approaches in drugs discovery. Dr. Sajid has worked in the well reputed international drugs discovery groups, including, the Institute of Organic and Biomolecular Chemistry, George August University of Gottingen, Germany, through HEC’s IRSIP program in 2007, at the Department of Chemistry, University of Turku, Finland under Erasmus Mundus’s Experts4asia faculty exchange fellowship in 2014. The American Society for Microbiology (ASM) awarded him the International Microbiology Educators award under ASMCUE program in 2015. Later in 2018, Dr. Sajid was awarded the prestigious US Fulbright fellowship and he completed one year postdoctoral research in 2018-2019 at the Center for Pharmaceutical Research and Innovation, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, USA.